GTBP icon

GT Biopharma

57 hedge funds and large institutions have $12.9M invested in GT Biopharma in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 28 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

less ownership

Funds ownership:

23% less capital invested

Capital invested by funds: $16.7M → $12.9M (-$3.83M)

82% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 28

Holders
57
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$156K
Puts
$135K
Net Calls
Net Calls Change

Top Sellers

1 -$629K
2 -$549K
3 -$506K
4
Renaissance Technologies
Renaissance Technologies
New York
-$347K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$290K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.31M
2
$2.85M
3
$1.39M
4
$1.04M
5
$768K
6
$537K
7
$472K
8
$409K
9
$204K
10
$148K
11
$142K
12
$135K
13
$111K
14
$93K
15
$87K
16
$86K
17
$82K
18
$81K
19
$74K
20
$62K
21
$58K
22
$54K
23
$53K
24
$52K
25
$48K